Literature DB >> 12500045

Why do Black Americans have a higher risk of pancreatic cancer than White Americans?

Debra T Silverman1, Robert N Hoover, Linda M Brown, G Marie Swanson, Mark Schiffman, Raymond S Greenberg, Richard B Hayes, Keith D Lillemoe, Janet B Schoenberg, Ann G Schwartz, Jonathan Liff, Linda M Pottern, Joseph F Fraumeni.   

Abstract

BACKGROUND: For several decades, the incidence of pancreatic cancer has been 50% to 90% higher among blacks than among whites in the United States. The purpose of this study was to identify risk factors that may contribute to this racial disparity.
METHODS: We conducted a population-based case-control study of pancreatic cancer diagnosed in Atlanta (GA), Detroit (MI), and 10 New Jersey counties from August 1986 through April 1989. In-person interviews were exclusively with subjects (526 cases and 2153 population controls), rather than with next of kin.
RESULTS: The determinants of the higher incidence of pancreatic cancer among blacks than among whites differed by sex. Among men, established risk factors (, cigarette smoking, long-term diabetes mellitus, family history of pancreatic cancer) account for 46% of the disease in blacks and 37% in whites, potentially explaining all but 6% of the excess risk among blacks. Among women, however, other factors appear to contribute to the racial disparity, notably moderate/heavy alcohol consumption (>7 drinks per week) and elevated body mass index (above the first quartile). When these less accepted risk factors were combined with the established risk factors, 88% of the disease in black women and 47% in white women were explained, potentially accounting for all of the excess risk among blacks in our female study population.
CONCLUSIONS: Among men, the established risk factors (mainly cigarette smoking and diabetes mellitus) explain almost the entire black/white disparity in incidence. Among women, however, other factors appear to contribute to the racial disparity, notably moderate/heavy alcohol consumption and elevated body mass index. In the absence of these factors, pancreatic cancer incidence rates among blacks probably would not exceed those among whites of either sex.

Entities:  

Mesh:

Year:  2003        PMID: 12500045     DOI: 10.1097/00001648-200301000-00013

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  46 in total

1.  Pancreatic cancer patients who smoke and drink are diagnosed at younger ages.

Authors:  Randall E Brand; Julia B Greer; Eugene Zolotarevsky; Rhonda Brand; Hongyan Du; Diane Simeone; Anna Zisman; Addi Gorchow; Shih-Yuan Connie Lee; Hemant K Roy; Michelle A Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

2.  Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma.

Authors:  Benjamin E Ueberroth; Adnan Khan; Kevin J Zhang; Philip A Philip
Journal:  J Gastrointest Cancer       Date:  2021-03

Review 3.  Racial Disparity in Gastrointestinal Cancer Risk.

Authors:  Hassan Ashktorab; Sonia S Kupfer; Hassan Brim; John M Carethers
Journal:  Gastroenterology       Date:  2017-08-12       Impact factor: 22.682

Review 4.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

5.  Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.

Authors:  Vanessa L Gordon-Dseagu; Susan S Devesa; Michael Goggins; Rachael Stolzenberg-Solomon
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

6.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.

Authors:  Vinamrata Singal; Ashwani K Singal; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

7.  Epidemiology of Pancreatic and Periampullary Cancer.

Authors:  Prabin Thapa
Journal:  Indian J Surg       Date:  2015-10-17       Impact factor: 0.656

8.  Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center.

Authors:  Kevin J Zhang; Greg Dyson; Joshua L Gatz; Michael E Silverman; Anteneh A Tesfaye; Anthony F Shields; Philip A Philip
Journal:  Am J Clin Oncol       Date:  2019-03       Impact factor: 2.339

9.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

10.  Treatment Access and Survival Amongst British Asians with Pancreatic Cancer.

Authors:  J Isherwood; D Bilku; M S Metcalfe; A R Dennison; G Garcea
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.